Table 5. Associations between doctors’ seniority and different methods of cooperation between Polish doctors and the pharmaceutical industry in the 12 months preceding the survey.
| Means of cooperation | Less than 5 years | 6–15 years | 16–25 years | Over 26 years | Statistic parameters | Total |
|---|---|---|---|---|---|---|
| 1. Participation as an audience member in a conference, presentation, meeting, or educational training organized by a pharmaceutical company. | 80.5% | 78.7% | 84.5% | 82.7% | χ2(3) 1.0, p = .79 | 81.9% |
| 2. Participation as a presenter in a conference, presentation, meeting, or educational training organized by a pharmaceutical company. | 7.3% | 12.0% | 17.9% | 19.1% | χ2(3) 4.3, p = .23 | 15.5% |
| 3. Participation in post-marketing examinations (Phase IV trials): completing a questionnaire about the reaction of patients to a medicine produced by a company. | 7.3% | 21.3% | 21.4% | 10.9% | χ2(3) 7.9, p < .05 | 15.9% |
| 4. Participation in a marketing survey sponsored by a pharmaceutical company about the work of pharmaceutical sales representatives. | 19.5% | 14.7% | 17.9% | 12.7% | χ2(3) 1.5, p = .67 | 15.5% |
| 5. Participation in free-for-patient examinations sponsored by a pharmaceutical company. | 0.0% | 5.3% | 7.1% | 4.5% | χ2(3) 5.0, p = .17 likelihood ratio | 4.9% |
| 6. Writing or endorsement of articles about a drug or active substance at the request of a pharmaceutical company. | 2.4% | 4.0% | 7.1% | 0.0% | χ2(3) = 10.5, p < .05 likelihood ratio | 3.2% |
Note. Total percentages do not add up to 100 because respondents could select all forms of cooperation engaged in during the previous 12 months.